|
⚲
|
| Keyboard |
| Arch Venture Partners XIII LLC | |
|---|---|
| Firm | Arch Venture Management LLC |
| Address | c/o Arch Venture Management, LLC 8755 W Higgins Road, Suite 1025 Chicago, IL 60631 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Arch Venture Management LLC | |||||
| Arch Venture Fund XIII LP | 021-504109 | Director | of 3,000.0 M |
3,309.7 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lyell Immunopharma Inc LYEL
Common Stock
|
2026-03-06 | Buy | 488,090 | $25.61 | 12,499,985 |
|
Metsera Inc MTSR
Common Stock
|
2025-11-13 | Disposed to issuer | 8,313,680 | ||
|
Metsera Inc MTSR
Common Stock
|
2025-11-13 | Disposed to issuer | 18,503,128 | ||
|
Metsera Inc MTSR
Common Stock
|
2025-02-03 | Conversion | 7,523,682 | ||
|
Metsera Inc MTSR
Series B Convertible Preferred Stock · derivative
|
2025-02-03 | Conversion | 2,678,571 | ||
|
Metsera Inc MTSR
Series A Convertible Preferred Stock · derivative
|
2025-02-03 | Conversion | 15,000,000 | ||
|
Metsera Inc MTSR
Common Stock
|
2025-02-03 | Conversion | 16,006,949 | ||
|
Metsera Inc MTSR
Series A Convertible Preferred Stock · derivative
|
2025-02-03 | Conversion | 15,000,000 | ||
|
Metsera Inc MTSR
Series Seed Preferred Stock · derivative
|
2025-02-03 | Conversion | 19,933,333 | ||
|
Metsera Inc MTSR
Series B Convertible Preferred Stock · derivative
|
2025-02-03 | Conversion | 2,678,571 | ||
|
Metsera Inc MTSR
Common Stock
|
2025-02-03 | Buy | 789,998 | $18.00 | 14,219,964 |
|
Metsera Inc MTSR
Common Stock
|
2025-02-03 | Buy | 1,432,224 | $18.00 | 25,780,032 |